Warning Letter — Quantum Star LLC
The FDA issued a Warning Letter to Quantum Star LLC following an inspection by the Office of Inspections and Investigations. The specific regulatory violations were not detailed in the available excerpt.
This affects Quantum Star LLC and its quality, regulatory, and operational departments responsible for ensuring compliance with FDA standards.
An official Warning Letter indicates that the FDA has identified significant violations of regulatory requirements. This suggests that the firm's previous responses to inspectional observations may have been deemed insufficient, potentially leading to further enforcement actions such as seizure, injunction, or civil money penalties if not addressed.
Conduct a gap analysis of current quality systems against FDA inspectional findings. Ensure all corrective actions are documented and validated before the agency's requested response deadline. Review communication protocols between the Office of Inspections and Investigations and internal compliance teams.
FDA Warning Letter issued to: Quantum Star LLC. 08/05/2026 — Office of Inspections and Investigations. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/quantum-star-llc-726568-08052026
Open in openFDA / FDA.gov